Targeting VPS41 induces methuosis and inhibits autophagy in cancer cells

Yue Liu1, Yong Sun1, Yuliang Xu1

  • 1Department of Natural Products Chemistry, Key Laboratory of Natural Products & Chemical Biology, Ministry of Education, School of Pharmaceutical Sciences, Shandong University, Jinan 250012, China.

Cell Chemical Biology
|January 28, 2023
PubMed

Insights

Methyl 2,4-dihydroxy-3-(3-methyl-2-butenyl)-6-phenethylbenzoate (DMBP) targets vacuolar protein sorting-associated protein 41 homolog (VPS41), inhibiting cancer cell proliferation via methuosis and restraining metastasis.

Area of Science:

  • Cell Biology
  • Molecular Oncology
  • Drug Discovery

Background:

  • The homotypic fusion and vacuole protein sorting (HOPS) complex is crucial for membrane trafficking in cellular processes like endocytosis and autophagy.
  • Dysfunction of HOPS subunits is linked to cancer, yet their therapeutic potential remains underexplored.

Purpose of the Study:

  • To investigate the anticancer mechanisms of methyl 2,4-dihydroxy-3-(3-methyl-2-butenyl)-6-phenethylbenzoate (DMBP).
  • To identify vacuolar protein sorting-associated protein 41 homolog (VPS41) as a key target of DMBP in cancer cells.

Main Methods:

  • Identified VPS41 as a direct target of the natural compound DMBP.
  • Investigated DMBP's effects on cancer cell phenotypes, including methuosis induction and autophagic flux inhibition.
  • Assessed DMBP's efficacy in a mouse model of metastatic melanoma.

Main Results:

  • DMBP inhibits VPS41 function, leading to methuosis and impaired autophagic flux in cancer cells.
  • DMBP restricts the fusion of late endosomes and autophagosomes with lysosomes.
  • DMBP demonstrated significant inhibition of metastasis in a preclinical mouse model.

Conclusions:

  • Targeting VPS41 with DMBP represents a novel therapeutic strategy against cancer proliferation.
  • DMBP-induced methuosis offers a potential pathway for developing new anticancer treatments.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
Autophagy01:27

Autophagy

Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
4.4K
Autophagic Cell Death01:18

Autophagic Cell Death

Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
3.5K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.8K
Delivery Pathways to the Lysosome01:36

Delivery Pathways to the Lysosome

Eukaryotic cells use different mechanisms to eliminate toxic waste obsolete and worn-out substances. Lysosomes play a pivotal role in this, and hence, these substances are carried to the lysosome from other parts of the cell and extracellular space through different pathways. The most elaborately studied pathways to the lysosome are the endocytic pathways.
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
6.7K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.7K